Home › Funds › Rubric Capital Management LP › ROIV

Rubric Capital Management LP position in ROIV

ROIVANT SCIENCES LTD · Health Care

Rubric Capital Management LP reported holding 6,000,000 shares of ROIV (ROIVANT SCIENCES LTD) in its Q2 2026 13F filing — a position valued at US$212.3M, representing 1.96% of its reported portfolio and ranking #15 among its reported holdings. Rubric Capital Management LP has disclosed ROIV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)6.00M sh
Reported value held$212.34M
Portfolio Weight1.96%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rubric Capital Management LP's ROIV position evolved

Rubric Capital Management LP first disclosed a stake in ROIV in Q3 2023 at 10,500,000 shares (US$122.6M). The position peaked in Q3 2025 at 20,000,000 shares, worth US$302.6M. Across 12 filings, Rubric Capital Management LP increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 6,000,000 shares valued at US$212.3M — an increase of 1,000,000 shares quarter over quarter.. Notable position changes include a 81% increase in Q4 2023 (shares fell 6% over the following quarter), a 55% trim in Q4 2025 (shares rose 28% over the following quarter), a 44% trim in Q1 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 10.50M $122.64M New
Q4 2023 19.00M $213.37M Add
Q1 2024 20.00M $210.80M Add
Q2 2024 23.00M $243.11M Add
Q3 2024 22.40M $258.50M Reduce
Q4 2024 20.00M $236.60M Reduce
Q1 2025 17.77M $179.27M Reduce
Q2 2025 20.37M $229.57M Add
Q3 2025 20.00M $302.60M Reduce
Q4 2025 9.00M $195.30M Reduce
Q1 2026 5.00M $138.50M Reduce
Q2 2026 6.00M $212.34M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ROIV and 13F data

ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 63 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), Farallon Capital Management (US$506.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ROIV

All ROIV fund holders →

FAQ

How long has Rubric Capital Management LP held ROIV?

Rubric Capital Management LP has disclosed ROIV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Rubric Capital Management LP's current position in ROIV?

As of Q2 2026, Rubric Capital Management LP holds 6.00M shares of ROIV (ROIVANT SCIENCES LTD), valued at $212.34M, representing 1.96% of its reported portfolio and ranking #15.

Has Rubric Capital Management LP been buying or selling ROIV?

In the latest 13F filing (Q2 2026), Rubric Capital Management LP increased its position in ROIV. The position peaked in Q3 2025 at 20.00M shares.

Which other funds hold ROIV?

Other major institutional holders of ROIV include QVT Financial LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 63 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.